Long‐Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER‐CN Study

Background Long‐term efficacy and safety of mavacamten in Chinese patients with obstructive hypertrophic cardiomyopathy are unknown. Methods Patients who completed the 30‐week, double‐blind, placebo‐controlled treatment period in EXPLORER‐CN (A Study to Evaluate the Efficacy and Safety of Mavacamten...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zhuang Tian, Xiaoyan Li, Liwen Li, Qing Zhang, Jian’an Wang, Yunqi Shi, Daoquan Peng, Wei Ma, Ping Yang, Xiang Cheng, Wei Jin, Fang Wang, Yimeng Xie, Beth Pan, Victoria Florea, Shuyang Zhang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-06-01
Edice:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:	long‐term outcomes mavacamten obstructive hypertrophic cardiomyopathy
On-line přístup:	https://www.ahajournals.org/doi/10.1161/JAHA.125.046251
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!